On-Line Monitoring of Apoptosis in Insulin-Secreting Cells
- Martin Köhler1,
- Sergei V. Zaitsev12,
- Irina I. Zaitseva12,
- Barbara Leibiger1,
- Ingo B. Leibiger1,
- Mikael Turunen1,
- Iouri L. Kapelioukh12,
- Linda Bakkman1,
- Ioulia B. Appelskog1,
- Jacques Boutet de Monvel34,
- Gabriela Imreh1 and
- Per-Olof Berggren1
- 1Rolf Luft Center for Diabetes Research, Department of Molecular Medicine, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden
- 2Belozersky Institute of Physico-Chemical Biology and Chemical School, Lomonosov Moscow State University, Moscow, Russia
- 3Center for Hearing and Communication Research and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- 4Department of Otolaryngology, Karolinska Hospital, Stockholm, Sweden
- Address correspondence and reprint requests to Martin Köhler, the Rolf Luft Center for Diabetes Research, Department of Molecular Medicine, Karolinska Institutet, Karolinska Hospital, SE-171 76 Stockholm, Sweden. E-mail: martin.kohler{at}molmed.ki.se
Abstract
Apoptosis was monitored in intact insulin-producing cells both with microfluorometry and with two-photon laser scanning microscopy (TPLSM), using a fluorescent protein based on fluorescence resonance energy transfer (FRET). TPLSM offers three-dimensional spatial information that can be obtained relatively deep in tissues. This provides a potential for future in vivo studies of apoptosis. The cells expressed a fluorescent protein (C-DEVD-Y) consisting of two fluorophores, enhanced cyan fluorescent protein (ECFP) and enhanced yellow fluorescent protein (EYFP), linked by the amino acid sequence DEVD selectively cleaved by caspase-3–like proteases. FRET between ECFP and EYFP in C-DEVD-Y could therefore be monitored on-line as a sensor of caspase-3 activation. The relevance of using caspase-3 activation to indicate β-cell apoptosis was demonstrated by inhibiting caspase-3–like proteases with Z-DEVD-fmk and thereby showing that caspase-3 activation was needed for high-glucose–and cytokine-induced apoptosis in the β-cell and for staurosporine-induced apoptosis in RINm5F cells. In intact RINm5F cells expressing C-DEVD-Y and in MIN6 cells expressing the variant C-DEVD-Y2, FRET was lost at 155 ± 23 min (n = 9) and 257 ± 59 min (n = 4; mean ± SE) after activation of apoptosis with staurosporine (6 μmol/l), showing that this method worked in insulin-producing cells.
- DIC, differential interference contrast
- DWT, discrete wavelet transform
- ECFP, enhanced cyan fluorescent protein
- EYFP, enhanced yellow fluorescent protein
- FRET, fluorescence resonance energy transfer
- IL-1β, interleukin-1β
- INF-γ, interferon-γ
- TNF-α, tumour necrosis factor-α
- TPLSM, two-photon laser scanning microscopy
- TUNEL, transferase-mediated dUTP nick-end labeling
Footnotes
-
M.K. and S.V.Z. contributed equally to this study.
-
- Accepted August 29, 2003.
- Received May 7, 2003.
- Revision received August 29, 2003.
- DIABETES














